First Transdermal Non-steroidal Anti-inflammatory Drug for Cattle

MSD Animal Health today introduced FINADYNE® Transdermal (flunixin meglumine) Pour-on solution which delivers consistent efficacy proven to reduce pyrexia (fever) associated with bovine respiratory disease (BRD). FINADYNE Transdermal Pour-on combines convenience with a novel delivery method that simplifies
administration for veterinarians and farmers alike.

“The launch of FINADYNE Transdermal Pour-on allows for a more convenient way to
relieve animals from fever, improve respiratory and depression scores associated with BRD,”
states Siddartha Torres, MSD Animal Health. “FINADYNE Transdermal Pour-on is the world’s
first non-parasiticide cattle product available with a transdermal route of administration and
builds on the legacy of FINADYNE as the pioneer injectable non-steroidal anti-inflammatory
drug.”

FINADYNE Transdermal Pour-on goes to work quickly and has been demonstrated to
reduce fever as early as four hours after administration. The innovative technology of
FINADYNE Transdermal Pour-on allows for rapid absorption of flunixin through the skin and into
the bloodstream. The efficient administration means there is no need for additional labor, head
gates or restraint that is commonly associated with injectable administration, which translates to
reduced cost per treatment.

Available in pre-calibrated packaging, FINADYNE Transdermal Pour-on makes it easy to
ensure the correct dose is given every time. The unique bottle is designed for proper application
along the animal’s back and the red-colored solution makes it simple to accurately and quickly
measure the dose volume for each animal.

“FINADYNE Transdermal Pour-on will become an important part of health programmes
where the reduction of fever associated with BRD is indicated as it makes quick work of treating
animals, and supports improved animal well-being,” states Martyn Phillips, MSD Animal Health.
“The novel application of FINADYNE Transdermal Pour-on simplifies a usually time-consuming
and strenuous process, making it easier for both the animals and the people that care for them”.

This new approach to reducing fever in cattle is in alignment with industry efforts to
continuously improve animal care. Transdermal application requires less handling, resulting in
less stress on animals and leading to inherent health and wellness advantages. It also offers the
added benefit of needle-free administration, with no injection site lesions and a higher-value end
product.

Source: MSD Animal Health